11 results on '"Kaushiki Chatterjee"'
Search Results
2. Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
- Author
-
Shovan Dutta, Anirban Ganguly, Kaushiki Chatterjee, Sheila Spada, and Sumit Mukherjee
- Subjects
cancer treatment ,immune response ,cancer therapeutic strategy ,tumor immune escape ,immune-oncology ,tumor immune microenvironment ,Biology (General) ,QH301-705.5 - Abstract
Immune checkpoint blockade (ICB) has emerged as a novel therapeutic tool for cancer therapy in the last decade. Unfortunately, a small number of patients benefit from approved immune checkpoint inhibitors (ICIs). Therefore, multiple studies are being conducted to find new ICIs and combination strategies to improve the current ICIs. In this review, we discuss some approved immune checkpoints, such as PD-L1, PD-1, and CTLA-4, and also highlight newer emerging ICIs. For instance, HLA-E, overexpressed by tumor cells, represents an immune-suppressive feature by binding CD94/NKG2A, on NK and T cells. NKG2A blockade recruits CD8+ T cells and activates NK cells to decrease the tumor burden. NKG2D acts as an NK cell activating receptor that can also be a potential ICI. The adenosine A2A and A2B receptors, CD47-SIRPα, TIM-3, LAG-3, TIGIT, and VISTA are targets that also contribute to cancer immunoresistance and have been considered for clinical trials. Their antitumor immunosuppressive functions can be used to develop blocking antibodies. PARPs, mARTs, and B7-H3 are also other potential targets for immunosuppression. Additionally, miRNA, mRNA, and CRISPR-Cas9-mediated immunotherapeutic approaches are being investigated with great interest. Pre-clinical and clinical studies project these targets as potential immunotherapeutic candidates in different cancer types for their robust antitumor modulation.
- Published
- 2023
- Full Text
- View/download PDF
3. Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis
- Author
-
Kaushiki Chatterjee, Sumit Mukherjee, Jonathan Vanmanen, Probal Banerjee, and Jimmie E. Fata
- Subjects
HPV E6 positive cervical cancer ,natural product ,resveratrol ,pterostilbene ,PCNA ,caspase-3 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Human papilloma virus (HPV)-induced cervical cancer is one of the most frequent cancers in women residing in underdeveloped countries. Natural compounds like polyphenols continue to be of scientific interest as non-toxic effective alternative treatments. Our previous work showed the efficacy of two polyphenols, resveratrol, and pterostilbene on human HeLa cells. Here we explored the in vitro anti-cancer activity and in vivo anti-tumor potential of these two structurally similar compounds on HPV oncogene E6 and E7 positive murine TC1 cells. In vitro analysis confirmed the cytotoxic potential of both resveratrol and pterostilbene compounds with each having a low IC50 value and each showing the ability to downregulate viral oncogene E6. Further in vivo studies on TC1 tumors developing in mice indicated that treatment with either resveratrol or pterostilbene can significantly inhibit tumor development, with both compounds capable of downregulating E6 and VEGF tumor protein levels. Interestingly, the decrease in tumor size in pterostilbene was associated with tumor cell apoptosis, as indicated by an upregulation of activated caspase-3 whereas in resveratrol-treated mice it was accompanied by arrest of cell cycle, as indicated by a downregulation of PCNA. Thus, resveratrol and pterostilbene can serve as potential antineoplastic agents against HPV E6+ tumors and may suppress tumor growth via two different mechanisms.
- Published
- 2019
- Full Text
- View/download PDF
4. Resveratrol and Pterostilbene Exhibit Anticancer Properties Involving the Downregulation of HPV Oncoprotein E6 in Cervical Cancer Cells
- Author
-
Kaushiki Chatterjee, Dina AlSharif, Christina Mazza, Palwasha Syar, Mohamed Al Sharif, and Jimmie E. Fata
- Subjects
cervical cancer ,resveratrol ,pterostilbene ,HPV E6 ,p53 ,cell cycle ,Nutrition. Foods and food supply ,TX341-641 - Abstract
Cervical cancer is one of the most common cancers in women living in developing countries. Due to a lack of affordable effective therapy, research into alternative anticancer compounds with low toxicity such as dietary polyphenols has continued. Our aim is to determine whether two structurally similar plant polyphenols, resveratrol and pterostilbene, exhibit anticancer and anti-HPV (Human papillomavirus) activity against cervical cancer cells. To determine anticancer activity, extensive in vitro analyses were performed. Anti-HPV activity, through measuring E6 protein levels, subsequent downstream p53 effects, and caspase-3 activation, were studied to understand a possible mechanism of action. Both polyphenols are effective agents in targeting cervical cancer cells, having low IC50 values in the µM range. They decrease clonogenic survival, reduce cell migration, arrest cells at the S-phase, and reduce the number of mitotic cells. These findings were significant, with pterostilbene often being more effective than resveratrol. Resveratrol and to a greater extent pterostilbene downregulates the HPV oncoprotein E6, induces caspase-3 activation, and upregulates p53 protein levels. Results point to a mechanism that may involve the downregulation of the HPV E6 oncoprotein, activation of apoptotic pathways, and re-establishment of functional p53 protein, with pterostilbene showing greater efficacy than resveratrol.
- Published
- 2018
- Full Text
- View/download PDF
5. Targeting Signaling Pathways in Solid Tumors Part B
- Author
-
Sumit Mukherjee, Kaushiki Chatterjee, Sumit Mukherjee, and Kaushiki Chatterjee
- Abstract
Targetting Signaling Pathways in Solid tumour Part B, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors. - Provides the latest information on cancer research - Offers outstanding and original reviews on a range of cancer research topics - Serves as an indispensable reference for researchers and students alike
- Published
- 2024
6. Targeting Signaling Pathways in Solid Tumors Part A
- Author
-
Sumit Mukherjee, Kaushiki Chatterjee, Sumit Mukherjee, and Kaushiki Chatterjee
- Abstract
Targeting Signaling Pathways in Solid Tumors, Part A, Volume 385 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on topics such as Drugging the Undruggable: Advances in Targeting KRAS Signaling in Solid Tumors, Emerging Trends in Gastrointestinal Cancers: Targeting Developmental Pathways in their Carcinogenesis and Tumor Progression, Importance of targeting various cell signaling pathways in solid cancers, Targeting signaling pathways in cancer stem cells: a potential approach for developing novel anticancer therapeutics, Factors affecting heterogeneity in breast cancer microenvironment: A narrative review, and much more.Additional sections cover Exploring TLR Signaling Pathways as Promising Targets in Cervical Cancer: The Road Less Travelled - Provides the latest information on cancer research - Offers outstanding and original reviews on a range of cancer research topics - Serves as an indispensable reference for researchers and students alike
- Published
- 2024
7. Targeting Signaling Pathways in Solid Tumors Part C
- Author
-
Sumit Mukherjee, Kaushiki Chatterjee, Sumit Mukherjee, and Kaushiki Chatterjee
- Abstract
Targeting Signaling Pathways in Solid Tumors, Part C, Volume 389 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on topics such as Drugging the Undruggable: Advances in Targeting KRAS Signaling in Solid Tumors, Emerging Trends in Gastrointestinal Cancers: Targeting Developmental Pathways in their Carcinogenesis and Tumor Progression, Importance of targeting various cell signaling pathways in solid cancers, Targeting signaling pathways in cancer stem cells: a potential approach for developing novel anticancer therapeutics, Factors affecting heterogeneity in breast cancer microenvironment: A narrative review, and much more.Additional sections cover Exploring TLR Signaling Pathways as Promising Targets in Cervical Cancer: The Road Less Travelled - Provides the latest information on cancer research - Offers outstanding and original reviews on a range of cancer research topics - Serves as an indispensable reference for researchers and students alike
- Published
- 2024
8. Unique synergistic formulation of curcumin, epicatechin gallate and resveratrol, tricurin, suppresses HPV E6, eliminates HPV+ cancer cells, and inhibits tumor progression
- Author
-
Samay Sampat, Probal Banerjee, Anita Szerszen, Jimmie E. Fata, Juliet N E Baidoo, Sumit Mukherjee, Joseph P Navarra, Rahman Hussaini, Kaushiki Chatterjee, Priya Ranjan Debata, Elena Severinova, and Mario R. Castellanos
- Subjects
0301 basic medicine ,Gerontology ,cervical cancer ,Pharmacology ,Resveratrol ,HeLa ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,synergism ,Medicine ,curcumin ,Human papillomavirus ,human papillomavirus ,biology ,business.industry ,Combination index ,biology.organism_classification ,030104 developmental biology ,Epicatechin gallate ,Oncology ,chemistry ,combination index ,Tumor progression ,030220 oncology & carcinogenesis ,Cancer cell ,Curcumin ,business ,Research Paper - Abstract
// Sumit Mukherjee 1, 3, 5, * , Priya Ranjan Debata 5, 8, * , Rahman Hussaini 5 , Kaushiki Chatterjee 2, 4 , Juliet N.E. Baidoo 1, 3 , Samay Sampat 5 , Anita Szerszen 6 , Joseph P. Navarra 7 , Jimmie Fata 2 , Elena Severinova 6, 9 , Probal Banerjee 1, 5 and Mario R. Castellanos 6 1 Department of Chemistry, The College of Staten Island (CUNY), New York, NY, USA 2 CUNY Doctoral Program in Biology, CUNY Graduate Center, New York, NY, USA 3 CUNY Doctoral Program In Biochemistry, CUNY Graduate Center, New York, NY, USA 4 Department of Biology, The College of Staten Island (CUNY), New York, NY, USA 5 Center of Developmental Neuroscience, The College of Staten Island (CUNY), New York, NY, USA 6 Division of Research, Department of Medicine, Staten Island University Hospital (Northwell Health), New York, NY, USA 7 College of Pharmacy and Health Sciences, St. John’s University, New York, NY, USA 8 Current Address: Department of Zoology North Orissa University Baripada, Mayurbhanj, Odisha, India 9 Current Address: Cell Biology and Molecular Medicine, Rutgers University, Newark, NJ, USA * These authors contributed equally to this work Correspondence to: Probal Banerjee, email: probal.banerjee@csi.cuny.edu , probalbanerjee@yahoo.com Keywords: curcumin, cervical cancer, human papillomavirus, synergism, combination index Received: May 31, 2016 Accepted: September 02, 2016 Published: March 29, 2017 ABSTRACT Curcumin (from curry) (C) is highly potent against cervical cancer cells (CCC), but poor bioavailability has limited its clinical use. Similar natural polyphenols resveratrol (from grapes) (R), and epicatechin gallate (from green tea) (E) also display activity against CCC. By treating CCC (HeLa) with C, E, or R, or combinations of these compounds, we computed combination indices and observed a strong synergism among C, E, and R at the unique molar ratio 4:1:12.5. This combination, named as TriCurin, rapidly down regulated HPV18 E6 and NF-kB expression while concomitantly inducing the tumor suppressor protein p53 in HeLa cells. In the mouse c-Ha-ras and HPV16 E6, E7-expressing TC-1 CCC, both C and TriCurin elicited suppression of E6, induction of both p53 and acetyl-p53 (activated p53), and activation of caspase-3, but the TriCurin-evoked changes were several-fold greater than that produced by curcumin (4.7-fold for E6 inhibition, and 2-fold, 6-fold, and 1.7-fold for the induction of p53, acetyl-p53, and active caspase-3, respectively). Consequently, TriCurin was more potent in killing TC-1 and HeLa cells. Intralesional TriCurin treatment of tumors generated in mice by subcutaneously implanting the TC-1 CCC caused an 80–90% decrease in tumor growth. The ability of C to eliminate HeLa cells was significantly stabilized when delivered as TriCurin than when delivered alone. Topical application of TriCurin dispersed in a cream base afforded efficient transfer of C across the skin. Subcutaneous TriCurin injection yielded no adverse effect in tumor-naive healthy mice. Thus, TriCurin is a safe and promising therapeutic agent against HPV-associated disease.
- Published
- 2017
9. Rapid bactericidal activity of an amphiphilic polyacrylate terpolymer system comprised of same-centered comonomers with 2-carbon and 6-carbon spacer arms and an uncharged repeat unit
- Author
-
Jimmie E. Fata, Ashish Punia, Kaushiki Chatterjee, Sumit Mukherjee, Nan-Loh Yang, Kamia Punia, Probal Banerjee, and Krishnaswami Raja
- Subjects
chemistry.chemical_classification ,biology ,General Chemical Engineering ,Comonomer ,Cationic polymerization ,02 engineering and technology ,General Chemistry ,010402 general chemistry ,021001 nanoscience & nanotechnology ,biology.organism_classification ,01 natural sciences ,Bacterial cell structure ,0104 chemical sciences ,chemistry.chemical_compound ,chemistry ,Amphiphile ,Polymer chemistry ,0210 nano-technology ,Antibacterial activity ,Alkyl ,Bacteria ,Repeat unit - Abstract
The global health threat of antimicrobial resistance has created a pressing need to develop practical alternatives to conventional antibiotic agents. Peptide mimetic synthetic amphiphilic polymers are known to non-specifically disrupt the bacterial cell surface thus leading to highly hindered bacterial resistance development. We investigated the antibacterial activities of a terpolymer macromolecular architecture with a combination of 6-carbon and 2-carbon spacer arms (distance from polymer backbone to pendent cationic center) interspersed with counits with hydrophobic side groups. A random copolymer with a combination of 6-carbon spacer arm repeat units (60 mol%) and 2-carbon spacer arm (40 mol%) units is moderately active against bacteria and shows very low hemolytic activity. Incorporation of comonomer units with alkyl side groups, by replacing different levels of 2-carbon spacer arm counit, led to substantial increments in antibacterial activities without detrimental effects on hemolytic activities leading to highly selective (bacteria over red blood cells) antibacterial activity. Time-kill studies revealed rapid bactericidal activity of the terpolymer against both Staphylococcus aureus and Escherichia coli with 100% killing efficiency achieved within 1 h of polymer treatment, corresponding to a 5-log reduction of bacterial colony forming units. These results indicate the high potential of this amphiphilic terpolymer architecture in the development of alternatives to antibiotics.
- Published
- 2017
10. Context-Dependent Requirement of Euchromatic Histone Methyltransferase Activity during Reprogramming to Pluripotency
- Author
-
Aristotelis Tsirigos, Jorge Morales-Valencia, Effie Apostolou, Yixiao Gong, Alexander Polyzos, Valentina Snetkova, Bhishma Amlani, Sang Yong Kim, Ly-Sha Ee, Kaushiki Chatterjee, Emily Swanzey, Hongsu Wang, Chaitanya N. Parikh, Simon E. Vidal, Shengjiang Tu, Matthias Stadtfeld, and Jane A. Skok
- Subjects
0301 basic medicine ,Histone methyltransferase activity ,Methyltransferase ,Induced Pluripotent Stem Cells ,Biochemistry ,Methylation ,Article ,EHMT2 ,Histones ,epigenetic remodeling ,03 medical and health sciences ,Mice ,0302 clinical medicine ,EHMT2 cellular reprogramming ,Genetics ,Animals ,Induced pluripotent stem cell ,EHMT1 ,biology ,Cell Biology ,Histone-Lysine N-Methyltransferase ,Ascorbic acid ,Cellular Reprogramming ,Cell biology ,030104 developmental biology ,Histone ,H3K9 methylation ,biology.protein ,ascorbic acid ,Reprogramming ,030217 neurology & neurosurgery ,Developmental Biology ,induced pluripotency - Abstract
Summary Methylation of histone 3 at lysine 9 (H3K9) constitutes a roadblock for cellular reprogramming. Interference with methyltransferases or activation of demethylases by the cofactor ascorbic acid (AA) facilitates the derivation of induced pluripotent stem cells (iPSCs), but possible interactions between specific methyltransferases and AA treatment remain insufficiently explored. We show that chemical inhibition of the methyltransferases EHMT1 and EHMT2 counteracts iPSC formation in an enhanced reprogramming system in the presence of AA, an effect that is dependent on EHMT1. EHMT inhibition during enhanced reprogramming is associated with rapid loss of H3K9 dimethylation, inefficient downregulation of somatic genes, and failed mesenchymal-to-epithelial transition. Furthermore, transient EHMT inhibition during reprogramming yields iPSCs that fail to efficiently give rise to viable mice upon blastocyst injection. Our observations establish novel functions of H3K9 methyltransferases and suggest that a functional balance between AA-stimulated enzymes and EHMTs supports efficient and less error-prone iPSC reprogramming to pluripotency., Graphical Abstract, Highlights • EHMT function during mouse cell reprogramming is modulated by ascorbic acid (AA) • EHMT inhibition counteracts reprogramming in the presence of AA • EHMT inhibition in the presence of AA results in global erasure of H3K9 dimethylation • Cells reprogrammed in the presence of EHMT inhibitor are functionally impaired, In this article, Stadtfeld and colleagues show that the activity of a specific repressive histone methyltransferase is important for efficient cellular reprogramming under conditions that favor global histone demethylation. Their observations suggest that a balance between antagonizing chromatin modifiers is important to achieve faithful resetting of the epigenome during the generation of induced pluripotent stem cells.
- Published
- 2019
11. Resveratrol and Pterostilbene Exhibit Anticancer Properties Involving the Downregulation of HPV Oncoprotein E6 in Cervical Cancer Cells
- Author
-
Dina AlSharif, Kaushiki Chatterjee, Christina Mazza, Jimmie E. Fata, Mohamed Al Sharif, and Palwasha Syar
- Subjects
0301 basic medicine ,p53 ,pterostilbene ,Pterostilbene ,cervical cancer ,Down-Regulation ,Uterine Cervical Neoplasms ,lcsh:TX341-641 ,Antineoplastic Agents ,Apoptosis ,Resveratrol ,resveratrol ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,Inhibitory Concentration 50 ,0302 clinical medicine ,Downregulation and upregulation ,Stilbenes ,medicine ,Humans ,Cervical cancer ,Nutrition and Dietetics ,Caspase 3 ,food and beverages ,Polyphenols ,HPV E6 ,cell cycle ,Cell migration ,Cell Cycle Checkpoints ,Oncogene Proteins, Viral ,Cell cycle ,medicine.disease ,Up-Regulation ,DNA-Binding Proteins ,Repressor Proteins ,030104 developmental biology ,chemistry ,Mechanism of action ,030220 oncology & carcinogenesis ,Cancer research ,Female ,medicine.symptom ,Tumor Suppressor Protein p53 ,lcsh:Nutrition. Foods and food supply ,Food Science ,HeLa Cells - Abstract
Cervical cancer is one of the most common cancers in women living in developing countries. Due to a lack of affordable effective therapy, research into alternative anticancer compounds with low toxicity such as dietary polyphenols has continued. Our aim is to determine whether two structurally similar plant polyphenols, resveratrol and pterostilbene, exhibit anticancer and anti-HPV (Human papillomavirus) activity against cervical cancer cells. To determine anticancer activity, extensive in vitro analyses were performed. Anti-HPV activity, through measuring E6 protein levels, subsequent downstream p53 effects, and caspase-3 activation, were studied to understand a possible mechanism of action. Both polyphenols are effective agents in targeting cervical cancer cells, having low IC50 values in the µM range. They decrease clonogenic survival, reduce cell migration, arrest cells at the S-phase, and reduce the number of mitotic cells. These findings were significant, with pterostilbene often being more effective than resveratrol. Resveratrol and to a greater extent pterostilbene downregulates the HPV oncoprotein E6, induces caspase-3 activation, and upregulates p53 protein levels. Results point to a mechanism that may involve the downregulation of the HPV E6 oncoprotein, activation of apoptotic pathways, and re-establishment of functional p53 protein, with pterostilbene showing greater efficacy than resveratrol.
- Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.